Keywords: Novartis, Fourth-quarter and full-year 2010 financial results

Novartis sees 4th-qtr 2010 net income fall 6% but still beats expectations

Article | 27 January 2011

Print This

As a result of lower flu vaccine sales and a cancer drug candidate write-down, Swiss drug major Novartis (NOVN: VX) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in